Rheumatoid arthritis: JAK-ing up inadequate RA therapy
- PMID: 28680135
- DOI: 10.1038/nrrheum.2017.114
Rheumatoid arthritis: JAK-ing up inadequate RA therapy
Comment on
- 
  
  Efficacy and safety of tofacitinib monotherapy, tofacitinib with methotrexate, and adalimumab with methotrexate in patients with rheumatoid arthritis (ORAL Strategy): a phase 3b/4, double-blind, head-to-head, randomised controlled trial.Lancet. 2017 Jul 29;390(10093):457-468. doi: 10.1016/S0140-6736(17)31618-5. Epub 2017 Jun 16. Lancet. 2017. PMID: 28629665 Clinical Trial.
References
- 
    - Lancet. 2017 Jul 29;390(10093):457-468 - PubMed
 
Publication types
MeSH terms
Substances
LinkOut - more resources
- Full Text Sources
- Other Literature Sources
- Medical
 
        